ARTICLE
Auteur(s) : Renato Covello1, Stefano Licci2,
Angela Ferrari3, Luca Morelli4, Caterina
Catricalà3
1Department of Pathology, National Cancer
Institute “Regina Elena”, Rome, Italy
2Department of Pathology, “Santo Spirito” Hospital,
Lungotevere in Sassia, 100193 Rome, Italy
3Department of Dermatologic Oncology, Dermatologic
Institute “Santa Maria and San Gallicano”, Rome, Italy
4Department of Pathology, “Santa Chiara” Hospital,
Trento, Italy
A 69-year-old woman presented for a one year history of a skin
lesion on her left thumb with rapid growth in recent months. She
had no palpable lymphoadenopathy on clinical examination. The
lesion appeared as a pink, ulcerated nodule, suspicious for
squamous cell carcinoma.
Histologically, the lesion consisted of a nodular ulcerating
neoplasia, deeply infiltrating into the dermis and subcutaneous
fat, composed of small round-to-oval malignant cells with scant
cytoplasm and a high mitotic rate, admixed with islands of squamous
cell carcinoma and an undoubtedly malignant spindle cell tumour
(figures 1ABC). There was also a squamous cell carcinoma in
situ in the epidermidis close to the lesion (figure 1D). The small
cell component represented about 60% of the lesion, the squamous
cell component 30% and the spindle cell component 10%.
Immunohistochemistry showed that the small cell component was
strongly positive for NSE and for CK (AE1/AE3) and CK20, with a
paranuclear dot-like positivity (figure 1E), while
CK7, TTF1, vimentin, s-100 protein, smooth muscle actin (SMA),
desmin, caldesmon and HMB45 were all negative. The spindle cell
malignant component showed a strong positivity for vimentin,
desmin, SMA (figure 1F) and
caldesmon, while all the other markers were negative. The squamous
cell carcinoma component resulted positive only for CK
(AE1/AE3).
On the basis of the immunomorphological findings, a diagnosis of
MCC with squamous and leiomyosarcomatous differentiation was made.
One month later, the patient developed an ipsilateral axillary
lymphoadenopathy and a radical axillary lymph node dissection was
performed.
Ten of the twenty lymph nodes examined showed metastatic disease
with extranodal invasion. Unlike the primary neoplasm, only the
Merkel cell component, with an identical morphological and
immunohistochemical profile, was found in the metastasis. The
patient underwent adjuvant chemotherapy and regional radiotherapy
but, unfortunately, she died one year after the first
diagnosis.
MCC is a rare, aggressive, neuroendocrine carcinoma of the skin,
usually occurring in sun-damaged skin in the head and neck region
of elderly people [1]. Toker, who first described this tumour in
1972, called it trabecular carcinoma and supposed an eccrine
origin. Later, in 1978, with the ultrastructural demonstration of
neurosecretory granules in the cytoplasm of the tumour cells, a
neuroendocrine origin was postulated [2]. Recently, an epidermal
origin of Merkel cell has been supported, due to the observation of
an association between MCC and squamous cell carcinoma [3].
Interestingly, in these cases the clinical behaviour was highly
aggressive, as in typical MCC. Since the risk factors for MCC and
squamous cell carcinoma of the skin are overlapping, it can be
supposed they represent collision tumours [4]. The intimate
admixture of the different neoplastic cell types and the presence
in some cases of transition cells with features of both Merkel
cells and squamous cells suggest a common origin from the same stem
cell [3]. Moreover, six cases of Merkel cell carcinoma with
sarcomatous differentiation have been described [5], one of them
with a leiomyosarcomatous component [6]. In our case, the primary
lesion was represented by MCC with squamous and leiomyosarcomatous
differentiation, but only the MCC component was present in the
metastatic regional lymph nodes, unlike Hwang's case [5], in which
the metastatic lymph nodes displayed both the MCC and sarcomatous
components. A possible explanation could be that the MCC
component was the prevalent one, representing about 60% of the
whole lesion, while the leiomyosarcomatous part constituted only
about 10% of the tumour. Furthermore, MCC is more prone to give
rise to lymph node metastasis than squamous cell carcinoma,
representing, in our case, about 30% of the neoplasia. This finding
seems to suggest a possible role of the proportions of the
different components in the primary lesion in predicting the
metastasizing potential of the disease.
Acknowledgments
Financial support: none. Conflict of interest: none.
References
1 Sterry W, Chimenti S, MacKie R. Skin diseases in
Europe. Dermatooncology. Eur J Dermatol 2009; 19: 417-8.
2 Tang C, Toker C. Trabecolar carcinoma of the skin:
an ultrastructural study. Cancer 1978; 42: 2311-21.
3 Iacocca MV, Abernethy JL, Stefanato CM,
Allan AE, Bhawan J. Mixed Merkel cell carcinoma and
squamous cell carcinoma of the skin. J Am Acad Dermatol 1998; 39:
882-7.
4 Walsh N. Primary neuroendocrine (Merkel cell) carcinoma
of the skin: morphologic diversity and implications thereof. Hum
Pathol 2001; 32: 680-9.
5 Hwang JH, Alanen K, Dabbs KD, Danyluk J,
Silverman S. Merkel cell carcinoma with squamous and
sarcomatous differentiation. J Cutan Pathol 2008; 35: 955-9.
6 Cooper L, Debono R, Alsanjari N,
Al-Nafussi A. Merkel cell tumour with leiomyosarcomatous
differentiation. Histopathology 2000; 36: 540-3.
|